JP2009505968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009505968A5 JP2009505968A5 JP2008525343A JP2008525343A JP2009505968A5 JP 2009505968 A5 JP2009505968 A5 JP 2009505968A5 JP 2008525343 A JP2008525343 A JP 2008525343A JP 2008525343 A JP2008525343 A JP 2008525343A JP 2009505968 A5 JP2009505968 A5 JP 2009505968A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- cycloalkenyl
- heterocyclyl
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 66
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 54
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 52
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims 52
- 125000003710 aryl alkyl group Chemical group 0.000 claims 52
- 125000000623 heterocyclic group Chemical group 0.000 claims 52
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 36
- 125000003118 aryl group Chemical group 0.000 claims 36
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 32
- 125000001072 heteroaryl group Chemical group 0.000 claims 30
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 26
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000005843 halogen group Chemical group 0.000 claims 20
- 238000000034 method Methods 0.000 claims 17
- 150000001540 azides Chemical class 0.000 claims 16
- -1 hydroxy, carboxy Chemical group 0.000 claims 16
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 16
- 150000003573 thiols Chemical class 0.000 claims 16
- 125000004429 atom Chemical group 0.000 claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 12
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 8
- 125000000539 amino acid group Chemical group 0.000 claims 8
- 229910052805 deuterium Inorganic materials 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 4
- 125000006731 (C1-C8) thioalkoxy group Chemical group 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 4
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 4
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 4
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 4
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 4
- 239000004472 Lysine Substances 0.000 claims 4
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims 4
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims 4
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 4
- 239000004473 Threonine Substances 0.000 claims 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 4
- 235000004279 alanine Nutrition 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 4
- 235000003704 aspartic acid Nutrition 0.000 claims 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 229960003067 cystine Drugs 0.000 claims 4
- 150000001975 deuterium Chemical group 0.000 claims 4
- 150000002016 disaccharides Chemical group 0.000 claims 4
- 229930182830 galactose Natural products 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- 235000013922 glutamic acid Nutrition 0.000 claims 4
- 239000004220 glutamic acid Substances 0.000 claims 4
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 4
- 229960000310 isoleucine Drugs 0.000 claims 4
- 229930182817 methionine Natural products 0.000 claims 4
- 229950006780 n-acetylglucosamine Drugs 0.000 claims 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000006239 protecting group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 235000004400 serine Nutrition 0.000 claims 4
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims 4
- 150000004043 trisaccharides Chemical group 0.000 claims 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 4
- 239000004474 valine Substances 0.000 claims 4
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000003463 hyperproliferative effect Effects 0.000 claims 1
- 238000002428 photodynamic therapy Methods 0.000 claims 1
- 238000009214 sonodynamic therapy Methods 0.000 claims 1
- 0 CC(C(*)c1c(*)c(O)c2c3c1c1c(c(C(C=C4O)=O)c5O)c4c3C(O)=CC2=O)=Cc1c5N(*)* Chemical compound CC(C(*)c1c(*)c(O)c2c3c1c1c(c(C(C=C4O)=O)c5O)c4c3C(O)=CC2=O)=Cc1c5N(*)* 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70675505P | 2005-08-10 | 2005-08-10 | |
| US60/706,755 | 2005-08-10 | ||
| PCT/CA2006/001234 WO2007016762A1 (en) | 2005-08-10 | 2006-07-28 | Perylenequinone derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009505968A JP2009505968A (ja) | 2009-02-12 |
| JP2009505968A5 true JP2009505968A5 (https=) | 2009-09-17 |
| JP5205264B2 JP5205264B2 (ja) | 2013-06-05 |
Family
ID=37727044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525343A Expired - Fee Related JP5205264B2 (ja) | 2005-08-10 | 2006-07-28 | ペリレンキノン誘導体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8506931B2 (https=) |
| JP (1) | JP5205264B2 (https=) |
| AU (1) | AU2006279189B2 (https=) |
| CA (2) | CA2615510A1 (https=) |
| GB (1) | GB2442915B (https=) |
| WO (1) | WO2007016762A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2615510A1 (en) | 2005-08-10 | 2007-02-15 | Quest Pharmatech Inc. | Perylenequinone derivatives and uses thereof |
| US8454991B2 (en) * | 2006-07-24 | 2013-06-04 | Quest Pharmatech Inc. | Method and device for photodynamic therapy |
| CA2699140A1 (en) * | 2009-04-07 | 2010-10-07 | Quest Pharmatech Inc. | Nanoparticles for cancer sonodynamic and photodynamic therapy |
| JP5435722B2 (ja) * | 2010-01-22 | 2014-03-05 | 学校法人君が淵学園 | スーパーオキシドの分析方法およびスーパーオキシドの分析キット |
| CN101817790B (zh) * | 2010-03-14 | 2012-07-04 | 阜阳师范学院 | 一种由乙二胺修饰的痂囊腔菌素a类衍生物及其制备方法 |
| CA2935743A1 (en) | 2014-01-04 | 2015-07-09 | Vijay Agarwal | Device and method for use of photodynamic therapy |
| CN107405410B (zh) | 2015-01-15 | 2021-08-10 | OncoQuest制药有限公司 | 增加抗癌剂向靶递送的方法 |
| CN107935964B (zh) * | 2016-10-13 | 2020-09-25 | 中国科学院理化技术研究所 | 一种多取代近红外竹红菌素衍生物及其制备方法和应用 |
| WO2017067497A2 (zh) * | 2015-10-21 | 2017-04-27 | 中国科学院理化技术研究所 | 一种单取代或多取代的酯水双亲性竹红菌素衍生物及其制备方法和应用 |
| EP3366669B1 (en) * | 2015-10-21 | 2025-05-21 | Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences | Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof |
| CN105541647A (zh) * | 2015-10-21 | 2016-05-04 | 中国科学院理化技术研究所 | 含长链季铵盐的竹红菌素衍生物及其制备方法和应用 |
| CN106188114B (zh) * | 2016-07-13 | 2018-02-09 | 红河学院 | 氟硼取代竹红菌素衍生物的制备及其应用 |
| CN111825624B (zh) * | 2016-10-13 | 2021-07-27 | 中国科学院理化技术研究所 | 酯水双亲性竹红菌素衍生物及其制备方法和应用 |
| CN108245677B (zh) * | 2016-12-27 | 2021-04-02 | 中国科学院理化技术研究所 | 一种水溶性竹红菌素纳米组装体的应用 |
| CN107047461A (zh) * | 2017-04-06 | 2017-08-18 | 嘉应学院 | 五华三黄鸡j亚群禽白血病预防与净化喂养方法 |
| CN109456210B (zh) * | 2017-09-06 | 2020-09-25 | 中国科学院理化技术研究所 | 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用 |
| CN111885914B (zh) * | 2017-10-27 | 2022-05-13 | 投资健康有限责任公司 | 使用芴衍生物制造扩增的造血干细胞的组合物和方法 |
| CA3280998A1 (en) | 2019-02-13 | 2025-10-30 | Alpheus Medical, Inc. | Non-invasive sonodynamic therapy |
| WO2020243319A1 (en) | 2019-05-29 | 2020-12-03 | Sonalasense, Inc. | Sonosensitization |
| FR3100247B1 (fr) * | 2019-09-02 | 2021-08-06 | Centre Nat Rech Scient | Dérivé de phénazine et ses utilisations |
| CA3185803A1 (en) | 2020-08-07 | 2022-02-10 | Vijay Agarwal | Ultrasound arrays for enhanced sonodynamic therapy for treating cancer |
| US11813330B2 (en) | 2021-03-04 | 2023-11-14 | Theralase Technologies, Inc. | Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents |
| CN115536600B (zh) * | 2021-06-30 | 2025-02-18 | 中国科学院理化技术研究所 | 一种二胺取代的竹红菌素衍生物及制备方法和应用 |
| CN116135228B (zh) * | 2021-11-18 | 2025-06-13 | 中国科学院理化技术研究所 | 一种竹红菌素2-位氨基取代或乙二胺取代的衍生物在制备抗肿瘤光动力药物中的应用 |
| TWI898254B (zh) * | 2023-08-30 | 2025-09-21 | 國立臺灣大學 | 苝醌衍生物及其製備方法與用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08505054A (ja) | 1992-12-23 | 1996-06-04 | アイオア ステート ユニバーシティー リサーチ ファンデーション インコーポレーテッド | 分子フラッシュ |
| US6231593B1 (en) | 1994-03-21 | 2001-05-15 | Dusa Pharmaceuticals, Inc. | Patch, controller, and method for the photodynamic therapy of a dermal lesion |
| US5474528A (en) | 1994-03-21 | 1995-12-12 | Dusa Pharmaceuticals, Inc. | Combination controller and patch for the photodynamic therapy of dermal lesion |
| US5705103A (en) | 1996-11-22 | 1998-01-06 | Jame Fine Chemicals, Inc. | Composition for producing chemiluminescent light of controllable duration |
| AU6017198A (en) | 1997-01-10 | 1998-08-25 | Altarex Corp. | Substituted perylenequinones for use in photodynamic therapy |
| US5845640A (en) | 1997-01-24 | 1998-12-08 | Spectra Science Corporation | Chemiluminescent sources for photodynamic therapy and photomedicine |
| GB9710049D0 (en) | 1997-05-19 | 1997-07-09 | Nycomed Imaging As | Method |
| IL120891A0 (en) | 1997-05-22 | 1997-09-30 | Technion Res & Dev Foundation | Photodynamic and sonodynamic therapy and agents for use therefor |
| JP4663113B2 (ja) | 1997-09-05 | 2011-03-30 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗原刺激顆粒球媒介炎症を予防または軽減するための免疫刺激オリゴヌクレオチドの使用 |
| EP1085902A2 (en) | 1998-06-15 | 2001-03-28 | AltaRex Medical Corp. | Therapeutic compositions that produce an immune response by altering the antigen |
| JP3211027B2 (ja) | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
| US20020022032A1 (en) | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| ATE290879T1 (de) | 1999-08-18 | 2005-04-15 | Altarex Medical Corp | Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung |
| ES2254408T4 (es) | 2000-04-25 | 2007-10-01 | Immunex Corporation | Procedimiento de tratamiento de tumores usando terapia fotodinamica. |
| CN1349965A (zh) * | 2000-10-25 | 2002-05-22 | 中国科学院感光化学研究所 | 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途 |
| US20040110846A1 (en) | 2001-01-30 | 2004-06-10 | Beatrice Leveugle | Perylenequinones for use with immunotherapy agents |
| US6627664B2 (en) | 2001-01-30 | 2003-09-30 | Altachem Pharma Ltd. | Perylenequinones for use as sonosensitizers |
| CA2437563C (en) | 2001-02-06 | 2010-03-23 | Qlt Inc. | Photodynamic therapy of occult age-related macular degeneration |
| US6887862B2 (en) | 2001-05-31 | 2005-05-03 | Miravant Systems, Inc. | Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
| AU2003223613A1 (en) | 2002-04-16 | 2003-11-03 | Lumerx, Inc | Chemiluminescent light source using visible light for biotherapy |
| CN1600771A (zh) * | 2003-09-25 | 2005-03-30 | 中国科学院化学研究所 | 竹红菌乙素及其胺基衍生物类光敏剂的用途 |
| CN1600780A (zh) | 2003-09-25 | 2005-03-30 | 中国科学院化学研究所 | 环乙二胺基竹红菌乙素及其制备方法和用途 |
| CA2615510A1 (en) | 2005-08-10 | 2007-02-15 | Quest Pharmatech Inc. | Perylenequinone derivatives and uses thereof |
| US8454991B2 (en) | 2006-07-24 | 2013-06-04 | Quest Pharmatech Inc. | Method and device for photodynamic therapy |
-
2006
- 2006-07-28 CA CA002615510A patent/CA2615510A1/en not_active Abandoned
- 2006-07-28 JP JP2008525343A patent/JP5205264B2/ja not_active Expired - Fee Related
- 2006-07-28 WO PCT/CA2006/001234 patent/WO2007016762A1/en not_active Ceased
- 2006-07-28 AU AU2006279189A patent/AU2006279189B2/en not_active Ceased
- 2006-07-28 US US11/722,423 patent/US8506931B2/en not_active Expired - Fee Related
- 2006-07-28 GB GB0802753A patent/GB2442915B/en not_active Expired - Fee Related
- 2006-07-28 CA CA2820233A patent/CA2820233C/en not_active Expired - Fee Related
-
2013
- 2013-03-11 US US13/792,456 patent/US8758725B2/en active Active
- 2013-08-28 US US14/012,865 patent/US8747811B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009505968A5 (https=) | ||
| JP2013500304A5 (https=) | ||
| CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| JP2022542222A5 (https=) | ||
| JP2016527277A5 (https=) | ||
| TW200730540A (en) | Novel peptide compounds | |
| EA200900593A1 (ru) | Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака | |
| EP2457918A3 (en) | Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | |
| JP2018535255A5 (https=) | ||
| RU2013144368A (ru) | Пролекарства действующих веществ гетероциклическими линкерами | |
| RU2005125207A (ru) | Способ получения производного глутаминовой кислоты и производного пироглутаминовой кислоты и новое промежуточное соединение для получения этих производных | |
| CA2372063A1 (en) | Pyridopyranoazepine derivatives, their preparation and their therapeutic application | |
| JP2018529648A5 (https=) | ||
| WO2009056707A3 (fr) | Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique | |
| EA201071001A1 (ru) | Способ получения комбретастатина | |
| CN111302980A (zh) | 含硫酰氟基团的氨基酸类似物及其制备方法和应用 | |
| WO2008110690A3 (fr) | Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens | |
| EA018079B1 (ru) | Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона | |
| JP2009523139A5 (https=) | ||
| MX2008002068A (es) | Proceso de fluorinado de derivados de anilida y derivados de fluorinado de benzotiazole en la forma de agentes de generacion de imagen in vivo. | |
| JP2017036455A5 (https=) | ||
| JP7013048B2 (ja) | タンパク質及び／又はペプチド修飾用分子 | |
| JP2009523141A5 (https=) | ||
| WO2015181507A1 (fr) | Nouveaux composes de type 5-acylsulfanyl-histidine en tant que precurseurs des 5-sulfanylhistidines correspondantes et de leurs disulfures | |
| WO2020207279A1 (zh) | 一种唑啉季铵盐修饰分子中氨基的方法及其用途 |